Elaine Massaro, RN, gives us some detail on who should and can be involved in Shared Medical Appointments. She says that it often depends on the individual medical center as well as the city and state. Some she has visited across the country have included podiatrists, and she has even …

Elaine Massaro, RN, talks about the many challenges facing practitioners setting up an Shared Medical Appointment (SMA) system, but also explains how, ultimately, the benefits outweigh the challenges and work of setting up. Smoothing out these challenges is also something that Diabetes Educators can excel at, making the transition process …

Elaine Massaro introduces herself, and gives us a little of her background, letting us know why she is so enthusiastic about  Shared Medical Appointments. More videos with Elaine Massaro: Elaine Massaro, RN, Q1: What Is the Basic Concept of SMA’s? Elaine Massaro, RN, Q2: Long-term Studies on the Efficacy of …

Evan Sisson gives us a brief introduction of himself and the work that he is doing. More videos with Evan Sisson: Evan Sisson, PharmD, Q1: What Are the Current Guidelines on Lipid Treatment? Evan Sisson, PharmD, Q2: How Has the Definition of the “Right” Level for LDL Changed? Evan Sisson, …

Evan Sisson, PharmD, MHA, CDE, explains that the most recent guidelines on lipid treatments and therapies are actually from 2004, and that there has been a lot of research since then, so the medical community has been waiting for new guidelines for quite a while. He believes that the new guidelines …

Evan Sisson discusses how researchers are getting closer to an accurate picture of what an ideal LDL level is, and how this picture has changed over the years. He even mentions some people with unusually low levels of LDL — between 15 and 25 — speculating that we are probably …

Evan Sisson, PharmD, MHA, CDE, assistant professor at the Virginia Commonwealth University’s School of Pharmacy, outlines current thinking on the best LDL levels for our patients, and agrees with Steve that it is very confusing. There are many risk factors to be taken into account and we do not yet …

Evan Sisson answers the question: If you could have any LDL you wanted, irregardless of any disease, what would you want it to be? More videos with Evan Sisson: Evan Sisson, PharmD, MHA, CDE, Introduction Evan Sisson, PharmD, Q1: What Are the Current Guidelines on Lipid Treatment? Evan Sisson, PharmD, …

Evan Sisson talks about past concerns around statin risk and notes that there are many trials which have shown that statins, on their own, do not increase CV risk. However, he emphasizes that most of our patients with metabolic disease don’t just take a statin but are on other prescription …

Evan Sisson, notes that, even in the recent past, drug therapy was frequently “one-size-fits-all.” But now, newer agents are coming out that target other matebolic places which can affect LDL cholesterol in many different ways. As the medical community learns more about these other mechanisms, more tailored treatments may become …